GNH USA

Europe — EMA

Levetiracetam Relonchem

GNH USA supplies Levetiracetam Relonchem (Levetiracetam), an anticonvulsant for partial, generalized tonic‑clonic and myoclonic seizures. Request a quote.

Levetiracetam

Request sourcing

1
Pack/s

What is Levetiracetam?

Levetiracetam, the active ingredient in Levetiracetam Relonchem, is a Anticonvulsant presented as a tablet for oral use. It treats partial, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Relonchem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Levetiracetam used for?

Levetiracetam is used to manage seizure disorders within the epileptic disease spectrum.

Partial seizures: reduces frequency of focal onset seizures. Generalized tonic‑clonic seizures: helps control convulsive episodes. Myoclonic seizures: decreases sudden muscle jerks associated with this seizure type.

What are the side effects of Levetiracetam?

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: persistent tiredness or lack of energy. - Somnolence: increased sleepiness during the day. - Irritability: mood changes including agitation or hostility.

Serious or Rare Side Effects: - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Suicidal thoughts or depression: emergence of mood disorders requiring immediate medical attention. - Blood disorders: including leukopenia, thrombocytopenia, or anemia.

What precautions apply to Levetiracetam?

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure safe use.

Renal impairment: adjust dose based on creatinine clearance. Hepatic dysfunction: monitor liver enzymes and consider dose modification. Pregnancy: safety data are limited; use only if potential benefit justifies potential risk. Concomitant CNS depressants: may enhance sedation; monitor patient response. Mood changes: observe for depression, anxiety, or aggression, especially during treatment initiation. Store at ambient temperature: keep in the original container, protect from moisture and heat.

What does Levetiracetam interact with?

Levetiracetam can interact with other medicines, affecting its concentration or the effects of co‑administered drugs.

Major Interactions (Avoid): - Carbamazepine: strong enzyme inducer that markedly reduces levetiracetam plasma levels. - Phenytoin: induces metabolism leading to decreased efficacy of levetiracetam. - Phenobarbital: accelerates clearance, potentially compromising seizure control.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam levels, requiring observation for toxicity. - Topiramate: combined use can enhance central nervous system side effects. - Alcohol: additive sedative effects may increase dizziness and somnolence.

Frequently asked questions

What conditions is Levetiracetam Relonchem used to treat?+
Levetiracetam Relonchem is indicated for the treatment of partial (focal) seizures, generalized tonic‑clonic seizures, and myoclonic seizures in patients diagnosed with epilepsy. It helps reduce the frequency and severity of seizure episodes across these three recognized seizure types.
How does levetiracetam work to control seizures?+
Levetiracetam exerts its antiepileptic effect by binding to the synaptic vesicle protein SV2A. This binding modulates neurotransmitter release, stabilizes neuronal firing, and diminishes excessive synaptic excitation, thereby preventing the rapid, uncontrolled electrical discharges that cause seizures.
What determines the dose of Levetiracetam Relonchem?+
The appropriate dose of Levetiracetam Relonchem is individualized by the prescribing healthcare professional. Factors such as the patient’s age, renal function, seizure type, and response to therapy guide the prescriber’s decision on the exact dosage regimen.
Is Levetiracetam safe to use during pregnancy or breastfeeding?+
Safety data for levetiracetam in pregnancy are limited, and the drug is classified as having an unknown pregnancy category. It should be used only if the potential benefit to the mother outweighs any possible risk to the fetus. Breastfeeding mothers should consult their physician, as the drug is excreted in breast milk.
How do I order Levetiracetam Relonchem from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity of Levetiracetam Relonchem. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.
How does Levetiracetam compare with other antiepileptic drugs?+
Levetiracetam is distinguished by its unique SV2A binding mechanism, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancers such as valproic acid. It generally has a favorable drug‑interaction profile, fewer enzyme‑inducing effects, and is often chosen for patients who need a well‑tolerated option with minimal hepatic metabolism.
What are the recommended storage conditions for Levetiracetam Relonchem?+
Levetiracetam Relonchem should be stored at ambient temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture, direct sunlight and excessive heat to maintain product stability throughout its shelf life.
How is Levetiracetam administered to patients?+
Levetiracetam Relonchem is administered orally, typically as a tablet taken with or without food. The exact timing and frequency are determined by the prescriber, who may adjust the schedule based on the patient’s seizure pattern and renal function.
What are the most serious risks to watch for while taking Levetiracetam?+
Serious risks include severe skin reactions such as Stevens‑Johnson syndrome, emergence of suicidal thoughts or major depression, and hematologic abnormalities like leukopenia or thrombocytopenia. Patients should seek immediate medical attention if they notice rash, mood changes, or signs of infection.
Who should not use Levetiracetam Relonchem?+
Levetiracetam Relonchem is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is also advised for patients with severe renal impairment who may require dose adjustment, and it should be avoided in pregnant women unless the therapeutic benefit justifies potential risks.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Levetiracetam
Route
Oral Use
Manufacturer
Relon Chem Limited
Origin
EU

Related products